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Dynamic Changes in Lung MicroRNA Profiles During the
Development of Pulmonary Hypertension due to Chronic
Hypoxia and Monocrotaline
Paola Caruso, Margaret R. MacLean, Raya Khanin, John McClure, Elaine Soon, Mark Southgate,
Robert A. MacDonald, Jenny A. Greig, Keith E. Robertson, Rachel Masson, Laura Denby,
Yvonne Dempsie, Lu Long, Nicholas W. Morrell, Andrew H. Baker
Objective—MicroRNAs (miRNAs) are small noncoding RNAs that have the capacity to control protein production through
binding “seed” sequences within a target mRNA. Each miRNA is capable of potentially controlling hundreds of genes.
The regulation of miRNAs in the lung during the development of pulmonary arterial hypertension (PAH) is unknown.
Methods and Results—We screened lung miRNA profiles in a longitudinal and crossover design during the development of
PAH caused by chronic hypoxia or monocrotaline in rats. We identified reduced expression of Dicer, involved in miRNA
processing, during the onset of PAH after hypoxia. MiR-22, miR-30, and let-7f were downregulated, whereas miR-322 and
miR-451 were upregulated significantly during the development of PAH in both models. Differences were observed between
monocrotaline and chronic hypoxia. For example, miR-21 and let-7a were significantly reduced only in monocrotaline-treated
rats. MiRNAs that were significantly regulated were validated by quantitative polymerase chain reaction. By using in vitro
studies, we demonstrated that hypoxia and growth factors implicated in PAH induced similar changes in miRNA expression.
Furthermore, we confirmed miR-21 downregulation in human lung tissue and serum from patients with idiopathic PAH.
Conclusion—Defined miRNAs are regulated during the development of PAH in rats. Therefore, miRNAs may contribute
to the pathogenesis of PAH and represent a novel opportunity for therapeutic intervention. (Arterioscler Thromb Vasc
Biol. 2010;30:716-723.)
Key Words: pulmonary hypertension  small RNA molecules  gene regulation
Pulmonary arterial hypertension (PAH) is a complex disordercharacterized by the obstructive remodeling of pulmonary
arteries, leading to a progressive elevation in pulmonary arterial
pressure (PAP) and subsequent right-sided heart failure and
death.1 Familial PAH is associated in 80% of cases with diverse
heterozygous mutations in the gene-encoding bone morphoge-
netic protein receptor 2 (BMPR-II)2 and can be associated with
mutations in the activin–receptor kinaselike 1 gene.3 The cause
of the variable phenotypic expression of PAH among carriers of
mutated BMPR-II genes is unclear, and is likely related to
environmental and genetic modifiers. Although BMPR-II–re-
lated pathways are considered pivotal, many other mediator
pathways participate in the pathogenesis of PAH and are being
actively investigated, both independently and in combination.
For example, the involvement of serotonin in the development of
experimental PAH has been recently reported.4,5 Indeed, impor-
tant interactions between the serotonin and BMP pathways have
recently been described.6 Rats exposed to hypoxia or injected
with the toxin monocrotaline develop pulmonary arterial
changes correlated with the development of PAH, including
remodeling and elevating PAP.
MicroRNAs (miRNAs) are small noncoding transcripts of 16
to 29 nucleotide RNAs that regulate gene expression posttran-
scriptionally by targeting mRNAs. Animal miRNAs are pro-
cessed from longer primary transcripts (primary miRNAs) that
can contain multiple miRNAs.7 This precursor is then processed
in 3 steps. First, a complex comprising the nuclear RNase III
enzyme Drosha8 and the double strand (ds) RNA-binding
protein Pasha/DGCR89 cleaves the primary miRNA in a approx-
imately 60 nucleotides (nt) precursor miRNA hairpin. After this,
a shorter precursor is actively transported to the cytoplasm by
Exportin-5,10 where the precursor miRNA undergoes further
processing into an approximately 21- to 22-nt duplex (the mature
miRNA) by the multidomain ribonuclease Dicer and cofactors.11
One strand of the duplex is preferentially selected for entry into
a silencing complex that includes an argonaute protein. This
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mature miRNA guides the argonaute complex to complementary
sites on target transcripts.12
Recent studies have measured changes in the synthesis of
several thousand mRNAs and proteins in response to miRNA
transfection or endogenous miRNA knockdown and have found
that the major sequence determinant in the miRNA-mediated
downregulation of target mRNAs and proteins is the 6-mer
“seed” located in the 3 untranslated terminal regions (UTRs) of
mRNAs.13 Seed sequences in 3 UTRs were shown to be
strongly correlated with reduced protein production, whereas the
correlation was weaker but still detectable for seeds in coding
sequences.13 The interaction between miRNA and the seed
region leads to a blockade of translation via either cleavage of its
mRNA and/or translational repression.
Recently, a substantial level of interest in miRNAs has
demonstrated their fundamental role in disease pathogenesis.
Many recent studies14–16 have reported distinct miRNA signa-
tures in cancer cells. In the heart and vasculature, miRNAs are
associated with remodeling and the development of hypertrophy
and failure.17–19 In the lung, a recent study20 has highlighted the
regulation of miRNAs after smoke inhalation injury. Herein, we
use 2 distinct and commonly used rat models (hypoxic and
monocrotaline) of PAH to determine the regulation of miRNAs
during disease initiation and progression. We demonstrate time-
and insult-dependent changes in miRNA levels that may provide
new insights into pathways contributing to the pathobiology of
PAH and identify specific miRNAs that are targets for future
interventional studies.
Methods
A Supplement (available online at http://atvb.ahajournals.org) pro-
vides complete details on the methods used in this study.
Animal Models
Male Sprague-Dawley rats (age, 6 to 7 weeks; weight, 250 to 300
grams) were used throughout. Animals were anesthetized intramuscu-
larly with ketamine, 75 mg/kg, and zylazine, 6 mg/kg; and euthanized at
2, 7, and 21 days after the initiation of hypoxia or after monocrotaline
injection. Rats were exsanguinated, and the lungs were removed.
Two-Channel Microarray Experiment
A 2-channel microarray analysis using the MRA-1003 rat miRNA
microarray based on miRBase, version 10.1 (LC Sciences, Houston,
Tex) was used. Supplemental Figure IA depicts the design of the
miRNA microarray study investigating PAH in rats. To assess the
statistical significance of intergroup differences, rank products21 were
used. Significance was assessed using the false discovery rate multiple
testing correction method,22 with a false discovery rate cutoff of 5%.
Prediction of Potential miRNAs Targets
A list of targets for miR-21, miR-22, miR-30c, miR-451, and
miR-322 was obtained by searching 3 UTR sequences of rat
mRNAs for the seeds of miRNAs. Rat mRNAs were downloaded
from the USCS Genome Browser (available online at http://
genome.ucsc.edu/). Target mRNA expression was assessed in the
same samples used for miRNA analysis using assay kits (TaqMan,
Applied Biosystems, Foster City, Calif).
Transforming Growth Factor 1 and BMP4 Rat
Pulmonary Artery Endothelial Cells Stimulation
Passage 4 rat pulmonary artery endothelial cells (PASMC) were
cultured in 6-well plates in growth media. After 24 hours, the media was
replaced with serum-free media and cells were incubated for a further 24
hours. Wells were then incubated with 1 ng/mL of transforming growth
factor (TGF) 1 or 10 ng/mL of BMP4 or with Dulbecco-modified
Eagle growth media containing 0.1% heat-inactivated fetal calf serum as
a negative control. Total RNA was extracted after 5 and 24 hours of
stimulation and stored for quantitative polymerase chain reaction (q-
PCR) analysis of miR-451, miR-21, miR-22, miR-30c, and let-7f
expression.
Results
Time Course of Pulmonary Hemodynamics in
Hypoxia-Exposed and Monocrotaline-Treated Rats
Hemodynamic studies confirmed that both chronic hypoxia
and monocrotaline exposure resulted in the development of
PAH. In control rats, the mean PAP was 20.00.8 mm Hg.
In hypoxic animals, the mean PAP after 2, 7, and 21 days
was 24.81.2, 33.91.1, and 40.71.9 mm Hg, respec-
tively. In monocrotaline-exposed animals at the same time
points, the mean PAP was 19.90.8, 19.31.4, and
29.62.1 mm Hg, respectively.
Analysis of Genes Critical for miRNA Biogenesis
After the Initiation of PAH
First, we assessed the mRNA levels for genes critical to miRNA
biogenesis (ie, Dicer, Drosha, Pasha/DGCR8, and Exportin-5)
by TaqMan q-PCR analysis. Interestingly, we observed that in
vivo exposure to hypoxia induced a marked and sustained
decrease in mRNA for Dicer (Figure 1A and Supplemental
Figure IIA). Monocrotaline injury had a significant effect on
Dicer expression only 21 days after the treatment (Figure 1A). We
also quantified Dicer, Drosha, Pasha/DGCR8, and Exportin-5
mRNA expression in 24-hour hypoxic rat pulmonary artery fibro-
blasts (PAF), extracting RNA in sextuplicate from cells. In vitro,
Dicer expression was significantly downregulated by hypoxia (Fig-
ure 1B and Supplemental Figure IIB).
Global miRNA Profiling of the Lungs of Hypoxia-
and Monocrotaline-Treated Rats
The expression level of 350 miRNAs in the lung was investi-
gated using a 2-channel microarray experiment, allowing us to
identify their expression pattern during the first stages of PAH
pathogenesis (Supplemental Figure IB and Supplemental Table
I). We confirmed the prominent expression of miR-195 and
miR-200c in rat lung samples of control animals (data not
shown), consistent with the previous identification of these
miRNAs as the only lung-specific miRNAs.23 The expression of
miR-322, miR-451, miR-21, miR-22, miR-30c, let-7f, and let-7a
was the most significantly altered (Supplemental Table II) and
was, therefore, selected for further analysis. Further visualization
of miRNA dysregulation was observed using dot plots for
average values in each group plotted against each condition and
time point (Figure 2).
Validation of the miRNA Dysregulation
To validate the microarray analysis, the expression level of
miR-322, miR-451, miR-21, miR-22, miR-30c, let-7f, and let-7a
plus a control miRNA that was not altered in the lungs of treated
animals compared with controls (miR-145) was analyzed by
TaqMan q-PCR using total RNA extracted from both hypoxic
and monocrotaline-treated rats. As expected, and in agreement
with the profiling data, miR-145 levels were not altered under
either condition (Figure 3 and Supplemental Figure III). In
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contrast, miR-451, miR-322, let-7f, let-7a, miR-21, miR-22, and
miR-30c were significantly altered after injury (Figure 3 and
Supplemental Figure III). In particular, miR-451 expression
showed a strong upregulation in the hypoxic samples, and
reached a maximum 7 days after monocrotaline injection.
MiR-322 was significantly upregulated just 7 days after the
injury for both the models before returning to control levels by
day 21. MiR-22 expression showed differences between the 2
models, resulting in maximal downregulation after 21 days in
hypoxic conditions and 2 days after a monocrotaline injection.
MiR-21 and miR-30c showed a significant downregulation in
the monocrotaline and in the hypoxic model alone, respectively
(Figure 3 and Supplemental Figure III). Let-7f expression was
downregulated in both the models at early time points in the
hypoxic model (2 and 7 days after the induction of hypoxia) and
at later time points in the monocrotaline model (21 days after the
injection), whereas let-7a showed a significant downregulation
only 21 days after monocrotaline injection (Figure 3 and
Supplemental Figure III). We also quantified the expression
level of the miR-17–miR-92a cluster (miR-17, miR-19b, miR-
20a, and miR-92) in consideration of its recent involvement in
the regulation of BMPR-II. An array analysis showed no significant
dysregulation (Supplemental Table III). MiR-18a and miR-19a
were not assessed because they showed low expression on the array.
TaqMan q-PCR validations showed a small, but significant, upregu-
lation of miR-17, miR-19b, miR-20a, and miR-92 in the samples
(Supplemental Figure IV), consistent with a recent study.24
In Vitro Validation of miRNA Expression Level
Next, we assessed the expression level of miRNAs that were
downregulated (miR-22, miR-21, miR-30c, and let-7f) in in vitro
models of hypoxic injury to determine whether the hypoxic
insult in vitro paralleled the effect of miRNA profiles in vivo.
We extracted total RNA from normoxic and 24-hour hypoxic rat
PAFs and rat PASMCs and analyzed the samples by TaqMan
q-PCR for miRNA levels, normalizing this to the internal control
U87. The expression pattern for miR-22, miR-21, let-7f, and
miR-30c was quite similar to the in vivo analysis. In PAFs,
miR-22, let-7f, and miR-30c were significantly downregulated,
whereas miR-21 showed a similar expression level in both
normoxic and hypoxic cells (Figure 4A). In PASMCs, both
miR-22 and miR-30c showed a significant downregulation,
whereas miR-21 and let-7f did not show altered expression after
hypoxic treatment (Figure 4B). Thus, the exposure of rat PAFs
and PASMCs in vitro to hypoxia correlated well with the
changes in miRNAs observed in vivo. We also used 2 in vitro
Figure 1. In vivo and in vitro expression level of Dicer, Exportin-5, Drosha, and Pasha in hypoxic and monocrotaline-treated rats. A,
q-PCR analysis of hypoxic and monocrotaline-injected rats after 2, 7, and 21 days of exposure. Total RNA was extracted from hypoxic
(gray bars) or monocrotaline-injected (black bars) male rats at the age of 6 weeks. Results were normalized to GAPDH values and
expressed as relative fold change, with an arbitrary value of 1 assigned to the control (CTR) group. For statistical analysis, we con-
ducted a t test, checking each hypoxic or monocrotaline group vs the CTR group (*P0.05 and ***P0.001 vs CTR samples). B,
q-PCR analysis of hypoxic rat pulmonary arterial fibroblasts (PAF) showing the expression level of Dicer, Exportin-5 (Exp5), Pasha, and
Drosha after 24 hours of exposure. This experiment was performed with total RNA extracted from both the CTR and the hypoxic cells.
Results were normalized to GAPDH values (***P0.001 vs CTR samples).
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human cell models for assessing miRNA modulation. We
analyzed human fetal PAFs and human pulmonary artery endo-
thelial cells (PAEC) after 24-hour exposure to hypoxia. The
analysis of PAFs showed a significant dysregulation of all 4
miRNAs; in hypoxic PAECs, only miR-30c was modestly
downregulated (Supplemental Figure V). Because TGF- and
BMP are important regulators of pulmonary vascular SMC
signaling in PAH25 and the miR-451 promoter contains an
Smad-responsive element,26 we exposed rat PASMCs to
TGF-1 and BMP4 and assessed miR-451 levels. Both agonists
induced miR-451 levels significantly after 5 hours of stimulation
(Figure 4C). Notably, values returned to the unstimulated level
by 24 hours (Figure 4C). For a better understanding of the role
of TGF-1 in the dysregulation of our miRNAs of interest, we
also quantified the expression level of miR-21, miR-30, miR-22,
and let-7f after stimulation. TGF-1 stimulation induced the
same kind of dysregulation we observed in hypoxic and
monocrotaline-treated rats. In fact, all 4 miRNAs (miR-21,
miR-22, miR-30c, and let-7f) were downregulated in a time-
dependent manner (Figure 4D).
Prediction of Potential miRNA Targets
To identify a list of mRNA targets for miR-21, miR-22, and
miR-30c, we screened the 3 UTRs of mRNAs for the 6-mer
seeds of the miRNAs of interest. The seed is Watson-Crick
consecutive base pairing between mRNAs and the miRNAs at
nucleotide positions 2 to 7 from its 5 end. It has been
demonstrated using an unbiased computational approach applied
to high-throughput pulsed SILAC data sets that the seed se-
quence in the 3UTR is a primary motif that correlates with both
mRNA degradation and translational repression.13 Seed-based
target prediction methods had the highest overlap with pulsed
SILAC data. The accuracy of target prediction methods is
improved by using evolutionary conservation as an additional
filter (PicTar, TargetScanS, or Diana). However, the false-
positive rate of these target prediction methods, even with
conserved seed incorporation, is still around 40%. The relatively
mild extent of miRNA-mediated target downregulation has been
found to depend on the number of seeds of the miRNA of
interest and the distance between the adjacent seeds. Multiple
nonconserved seeds, in particular those located at optimal
distances of less than 40 nt, act synergistically.13,27 For example,
2 nonconserved seeds located within 40 nt appear to exert the
same effect as a single conserved seed (Raya Khanin, PhD,
unpublished data, 2009). In addition, seeds for different miRNAs
within an optimal distance may cooperatively regulate 1
target.27 The current target prediction algorithms do not
consider this. Therefore, we opted to search for 6-mer seeds
for miRNAs of interest in 3 UTRs of rat mRNAs. In particular,
we focused on those proteins that have multiple seeds for 1 or
more miRNAs located within a small distance on 3UTR. Based
on this, we generated a number of targets for downregulated
miRNAs (miR-21, miR-30c, and miR-22) (Supplemental Table
IV). The same strategy has been used for preliminary identifi-
Figure 2. Modulation of miRNA dysregula-
tion in PAH. Global miRNA data sets were
plotted on a log scale against each other to
identify those miRNAs that are dysregulated
both within disease groups and compared
with controls and longitudinally. Lines repre-
senting 2.5- and 5.0-fold changes are
shown. In each case, the x- and y-axes rep-
resent the average of 5 per group.
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cation of the potential targets of the 2 upregulated miRNAs
(miR-451 and miR-322) (Supplemental Table V). Several tar-
gets identified for the upregulated miRNA group are in common
with the group of downregulated miRNAs.
Analysis of miR-21, miR-22, and miR-30c Targets
in Hypoxic and Monocrotaline-Treated Lungs
Based on the targets identified in the Supplemental Table IV, we
performed TaqMan q-PCR validation analysis on the same sample
sets used for miRNA profiling (Supplemental Figure VI). In
general, a number of the predicted genes, but not all, were
regulated as expected. For example, KCNJ6 mRNA levels were
significantly enhanced after both hypoxia- and monocrotaline-
induced injuries (Supplemental Figure VI). MiR-21 was only
downregulated in monocrotaline-induced injury. Likewise,
TACC1, which has predicted targets for miR-21 and miR-30c,
was only upregulated in the monocrotaline-treated lungs, sug-
gesting that miR-21 is a key regulator in monocrotaline-induced
Figure 3. Validation of miRNA dysregulation. q-PCR analysis of hypoxic and monocrotaline-injected rats after 2, 7, and 21 days of
exposure. Total RNA was extracted from hypoxic (gray bars) or monocrotaline-injected (black bars) male rats at the age of 6 weeks.
Results were normalized to U87 values and expressed as relative fold change, with an arbitrary value of 1 assigned to the control (CTR)
group. *P0.05, **P0.005, and ***P0.001 vs CTR samples.
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PAH. Protein phosphatase 2, regulatory subunit B, epsilon
isoform (PPP2R5E) was upregulated only after monocrotaline-
induced injury, again perhaps indicative of miR-21 regulation.
Similarly, transforming growth factor, beta receptor 1 (TGFBR1), a
target of miR-22, showed significant upregulation selectively
in the monocrotaline model. The upregulation of YWHAZ
and TNRC6A only in the monocrotaline-treated rats could be
indicative of a significant role of miR-30c in gene regulation
after injury (Supplemental Figure VI). To validate the up-
regulation of targets at the protein level, we quantified by
western blot analysis the expression level of TGFBR1 in
monocrotaline day 7-treated and untreated rats. The signal
obtained from 4 samples for each group showed a significant
upregulation in monocrotaline-treated rats (Figure 5A). We
selected this target again for the relevant role of TGF-1 in
pulmonary vascular SMC signaling in PAH. On day 7, we
also localized TGFBR1 protein in paraffin sections from
control and monocrotaline-treated rat lungs with immunohis-
tochemistry assays. Again, this experiment showed TGFBR1
upregulation in the monocrotaline model 7 days after the
treatment (Figure 5B–D).
Expression Level of miR-21 and miR-451 in
Samples From Idiopathic Pulmonary Arterial
Hypertension in Humans
Considering the high level of dysregulation both in vivo and in
vitro of miR-451 and miR-21, and TGF-1 effect on their
expression level, we analyzed total RNA extracted from
paraffin-embedded lungs of patients with idiopathic pulmonary
arterial hypertension (PAH) and unaffected controls. A signifi-
cant downregulation of miR-21 was observed (Figure 6A).
Similarly, miR-21 downregulation in human samples was also
demonstrated in serum samples obtained from patients with
idiopathic PAH when compared with serum obtained from
unaffected controls (Figure 6B). MiR-451 was unaltered in both
lung tissue and serum (Figure 6).
Discussion
Gene regulation by miRNA in the progression of several
diseases is becoming increasingly relevant. Herein, we profiled
miRNA signatures in the rat lung and compared them longitu-
dinally with rats exposed to either chronic hypoxia or monocro-
taline injuries at 2, 7, and 21 days. We show that a small subset
of miRNAs is significantly changed (eg, miR-21, miR-22,
miR-30c, let-7f, let-7a, miR-322, and miR-451). These miRNA
profiles were validated by TaqMan q-PCR. The regulation of
these miRNAs was also mimicked in in vitro models involving
exposure of rat PAFs, rat PASMCs, human PAFs, and human
PAECs to hypoxia, or exposure of rat PASMCs to TGF- or
BMPs. By using bioinformatics analysis, we also predicted the
Figure 4. miRNA expression is regulated by
hypoxia in vitro and TGF-1–BMP4 stimula-
tion can induce the significant dysregulation
of miR-451, miR-21, miR-22, miR-30c, and
let-7f in PASMCs. A and B, q-PCR analysis
of hypoxic rat pulmonary arterial fibroblasts
(PAFs) (A) and PASMCs (B) showing the
expression level of miR-21, miR-22, miR-
30c, and let-7f after 24 hours of stimulation.
These experiments were performed with
total RNA extracted from both the control
(CTR) and the hypoxic cells. Results were
normalized to U87 values and expressed as
relative fold change, with an arbitrary value
of 1 assigned to the CTR group. C and D,
TGF-1 and BMP4 stimulation of rat
PASMCs. Passage 4 primary cells were
stimulated with total RNA extracted after 5
and 24 hours of stimulation from both non-
treated and stimulated rat PASMCs, and
each sample was analyzed in q-PCR tripli-
cate for testing miR-451 (C) and miR-21,
miR-22, miR-30c, and let-7f (D) expression level after 5 and 24 hours of stimulation. Results were normalized to U87 values and
expressed as relative fold change, with an arbitrary value of 1 assigned to the CTR group. *P0.05, **P0.005, and ***P0.001 vs CTR
samples.
Figure 5. Assessment of TGFBR1 protein expression level in
total rat lung protein extracts and its localization in rat lung par-
affin sections. A, TGFBR1 expression level was quantified by
Western blot analysis in proteins extracted from lung samples of
monocrotaline-treated rats on day 7 (Mday7) and control (CTR)
rats. Four samples were tested for each group, and the intensity
of the Western blot bands was measured using specific soft-
ware (Scion Image software). The resulting quantification bars
are represented in the graph, with the monocrotaline day 7
group represented by the gray bar (*P0.05 vs CTR samples).
TGFBR1 was localized in lung paraffin sections using an immu-
nohistochemistry assay. B, TGFBR1 staining in CTR rat lungs.
C, TGFBR1 staining in lungs after monocrotaline exposure for 7
days. D, Lung stained with a nonimmune isotype-IgG CTR
antibody.
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target sequences for these miRNAs, which predicted relevance
to genes involved in pathways known to be critical in PAH and
potentially novel genes. A number of predicted targets were
regulated in a manner predicted by the miRNA dysregulation
pattern. Moreover, an analysis of targets of the downregulated
miRNAs (ie, miR-21, miR-22, and miR-30c) and targets of the
upregulated miRNAs (ie, miR-451 and miR-322) showed the
presence of several target proteins in common, an indication of
the potential complex regulation of such targets in vivo. This
could explain why the expression level of several targets did not
always correlate with miRNA modulation.
Hypoxia and monocrotaline induced consistent changes in
miR-451 and to some extent miR-30c, yet regulated miR-21 and
miR-22 differently. This suggests that hypoxia- and
monocrotaline-induced PAH share some common elements
relating to miRNA regulation and differential regulation. Such
differential regulation is not entirely unexpected as the result of
the differential pathobiology induced by hypoxia and monocro-
taline. Monocrotaline challenge mainly targets the pulmonary
vascular endothelium and triggers the inflammatory process,
especially monocyte recruitment, both of which play an impor-
tant role in the course of human PAH.28–30 The course of
development of PAH is also different in each model, as is
well-known and confirmed in the present study. Hypoxia stim-
ulates changes in medial, adventitial, and endothelial layers of
the pulmonary artery; however, hypoxia leads to less inflamma-
tion than monocrotaline. The underlying pathobiology in both
models leads to differences at the protein level. For example, by
using a proteomic approach, it has recently been shown that in
the hypoxic model, proteins of the nitric oxide, carbon monox-
ide, and vascular endothelial growth factor pathways are signif-
icantly increased.31 In the monocrotaline model, proteins in-
volved in serotonin synthesis, the enhanced unfolded protein
response, and intracellular chloride channels are significantly
elevated.31
Dysregulation of BMP and TGF- signaling occurs in both
the hypoxic and monocrotaline models of PAH. Specifically,
reduced lung expression of BMPR-II and reduced signaling via
the downstream Smad1/5 pathway are observed.25 Conversely,
increased TGF- signaling is observed, with increased Smad3
phosphorylation and increased expression of TGF- target
genes.25 These effects are greater in the monocrotaline model
compared to exposure to chronic hypoxia. Interestingly, the
promoter region of miR-451 possesses an Smad3 response
element.26 Thus, activation of TGF- signaling could be respon-
sible for the increased expression of miR-451 observed in our
studies. TGF- stimulation was able to induce the downregula-
tion of miR-21, miR-22, miR-30c, and let-7f in our experiments.
The involvement and importance of miR-21 in disease patho-
genesis is becoming increasing well documented, especially for
the cardiovascular system. In blood vessel remodeling after
acute vascular injury, miR-21 is rapidly upregulated when it
associated with the development of intimal hyperplasia.32
Knockdown of miR-21 blocked development of the lesion,
suggesting a critical role for miR-21 in vascular pathology.
Herein, we show that miR-21 is selectively and consistently (at
all 3 points) downregulated after monocrotaline injection, but
not during hypoxic exposure. Therefore, in the lung after
exposure to monocrotaline, but not hypoxia, vascular remodel-
ing is associated with a substantial loss of miR-21. Therefore, it
will be important in future studies to ascertain the role of miR-21
in monocrotaline-induced pathology. BMPs are known to drive
smooth muscle cell differentiation via upregulation of miR-21.33
The downregulation of miR-21 in the monocrotaline model,
possibly related to reduced BMP signaling,25 may be involved in
the alteration of the smooth muscle cell phenotype that is seen in
PAH. Similarly, for other modulated miRNAs, it will be critical
to ascertain their role in disease pathology and to define the
potential effect of miRNA modulation in disease prevention. In
the future, it will be important to generate reliable methods to
deliver miRNA therapeutics to the lung efficiently and selec-
tively. This might require new strategies to modulate the tropism
of a gene delivery system (eg, viruses) and to generate selective
agents and cells.
We have focused on those miRNAs showing the largest
changes after the onset of injury. Three important recent studies
have shown that even subtle changes in miRNA lead to large
changes in phenotypes.13,27,34 Thus, the large changes we have
observed in miRNAs in this study are likely to strongly affect the
cell biology and pathobiology associated with the development
of PAH. The downregulation of miR-21 in idiopathic PAH
human samples suggests a potential important role for this
Figure 6. miR-21 and miR-451 expression level in
idiopathic PAH human samples. A, q-PCR analysis
of miR-21 and miR-451 expression level in
paraffin-embedded human lungs of patients with
idiopathic PAH and controls (CTRs). Samples were
normalized to Rnu-48 values and expressed as
relative fold change, with an arbitrary value of 1
assigned to the CTR group (**P0.005 vs CTR
samples). B, q-PCR analysis showing Ct values for
miR-21 and miR-451 expression in serum taken
from patients with idiopathic PAH (IPAH) and unaf-
fected CTRs. Ct, Cycle threshold, the number of
cycles it takes for a sample to reach the level
where the rate of amplification is the greatest dur-
ing the exponential phase.
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miRNA in human PAH. On the contrary, we did not observe
miR-451 upregulation in the same samples.
In summary, for the first time to our knowledge, we have
reported the global miRNA profiles of rat lungs after exposure to
hypoxia and monocrotaline injury. This highlights the potential
importance of miRNA in disease progression and possible
targets (either the miRNAs themselves or their mRNA targets)
for future therapeutic intervention.
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Supplement Material 
 
Supplement Methods 
TaqMan q-PCR Analysis of Mature miRNAs and mRNAs 
For the quantitative PCR (q-PCR), reactions were incubated in a 386-well optical plate at 
95 C for 10 min, following by 40 cycles of 95 C for 15 s and 60 C for 1 min. Results were 
normalized to U87 or Rnu-48 values for miRNAs and to GAPDH for gene expression. 
The fold change for every miRNA or mRNA expression was obtained. The q-PCRs for 
each miRNA or mRNA were run in triplicate and results are presented as the mean ± 
standard deviation of samples. To assess the statistical significance of intergroup 
differences, a Student’s t test was performed. 
 
MiRNA extraction from frozen lungs, PASMCs, PAFs, PAECs and human serum 
and reverse transcription 
Total RNA from tissues and cells were obtained using the miRNeasy kit (Qiagen, Hilden, 
Germany) following the manufacturer’s instructions, treated with the DNAse 1, 
amplification grade (Sigma, St. Louis, MO, USA), to eliminate the genome DNA 
contamination and quantified using the NanoDrop ND-1000 Spectrophotometer (Nano-
Drop Technologies, Wilmington, DE, USA). Absorbance of the RNA samples was 
quantified at 260 and 280 nm, and the 260/280 ratio was calculated. The samples 
showed a 260/280 ratio ≥ 1.9, which was assumed as an indicator of RNA purity. cDNA 
was synthesized from total RNA using stem-loop reverse transcription primers according 
to the TaqMan MicroRNA Assay protocol (Applied Biosystems, Foster city, CA, USA). 
Each reaction contained 50 ng of extracted total RNA, 50 nM stem-looped RT primer, 1 
× RT buffer, 0.25 mM each of dNTPs, 3.33 U/µl Multiscribe reverse transcriptase and 
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0.25 U/µl RNase inhibitor. The 15 ml reactions were incubated in a 96-well plate for 30 
min at 16 C, 30 min at 42 C, 5 min at 85 C and then held at 4 C. 
 
miRNAs extraction from paraffin-embedded human lungs 
The RecoverAll total RNA Isolation kit (Ambion, Streetsville, Canada) was used to 
extract total RNA (including miRNA) from FFPE samples. Three 10 µm slices were 
deparaffined with xylene for 3 min at 50°C, washed twice with ethanol, and digested with 
protease at 50°C for 15 min, then for 15 min at 80° C. The lysate was passed through a 
filter cartridge and DNAse digested, then RNA was eluted in 30 µl of RNAse free water 
and quantified using the NanoDrop ND-1000 Spectrophotometer (Nano-Drop 
Technologies, Wilmington, DE, USA). 
 
Primary Culture of Rat Pulmonary Artery Fibroblasts (PAFs) 
Male Wistar rats (specific pathogen free, Harlan UK Ltd, 6 weeks old; 300-400g) were 
used throughout.  Fibroblasts were prepared using the technique of Freshney 1.  
 
Primary Culture of Rat Pulmonary Artery Smooth Muscle Cells (PASMCs)  
Rat PASMCs were derived from small precapillary pulmonary arterioles using an iron 
oxide magnetic separation method, as previously described 2. 
 
Primary Culture of Human Pulmonary Endothelial Cells (PAECs)  
Human Pulmonary Endothelial Cells were obtained from Lonza (Lonza Group Ltd, Basel, 
Switzerland) and cultured by following the Supplier’s instructions.  
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Growth of Cells in a Hypoxic Environment 
A humidified temperature-controlled incubator (Galaxy R model, Wolf Laboratories, UK) 
was used as a hypoxic chamber. This incubator allows control of internal oxygen levels 
between 0 and 21% while CO2 level is simultaneously controlled at 5%. 
 
Western Blot Analysis 
Rat lung tissues removed from control and 7 day monocrotaline-treated male Sprague-
Dawley rats were homogenated in lysis buffer containing 150 mM NaCl, 20 mM Tris HCl 
pH 7.5, 1 mM EDTA, 1 mM EGTA, 1% Triton X 100, 2.5 mM napyrophosphate, 1 mM 
phenylmethylsulfonylfluoride (PMSF), 1 mM Na3VO4, 1 mM βglycerophosphate and 1 
µg/ml leupeptin. The homogenates were sonicated and incubated 20 min on ice. Lysed 
tissues were centrifuged at 14,000 rpm at 4°C for 1 5 min. The protein content was 
determined using a BCA assay (Pierce, Rockford, IL, USA). After blocking in TBS–
Tween 0.1%–Milk 10%, filter was incubated with an anti-TGFBR1 antibody (Santa Cruz 
Biotechnology Inc.) overnight at 4°C.  The membrane  was then incubated with 
secondary antibody (dilution 1:1000, goat anti-rabbit Abcam, Cambridge, UK) for 1 hour 
at room temperature. The ECL Western Blotting detection kit (Amersham, Little Chalfont, 
UK) was used to detect the presence of the protein of interest on the membrane. Equal 
sample loading was verified by stripping the blot and reprobing it with an anti-β-actin 
antibody (Abcam, Cambridge, UK). Protein quantification was performed with the Scion 
Image software (www.scioncorp.com): band intensities of the protein of interest were 
established and normalized to the relative β actin signal. 
 
 
Immunohistochemistry 
 
Rat lungs were fixed in 4% paraformaldehyde solution at 40C for 18 hours and 
embedded in paraffin. After deparaffinization with graded concentrations of xylene and 
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ethanol, slides were immersed in 3% H2O2 in phosphate buffered saline (PBS) for 30 
minutes at room temperature to block endogenous peroxidase activity.  Then, they were 
incubated with 20% normal goat serum for 30 minutes to reduce non-specific 
background staining. The sections were then incubated with rabbit anti-TGFBR1 
antibody (Abcam, Cambridge, UK) at 4 µg/ml or isotype matched rabbit IgG nonimmune 
control (Dako, High Wycombe, UK). Sections were then incubated with appropriate 
biotinylated secondary antibody (Dako, High Wycombe, UK) diluted 1:200 in 1% (w/v) 
BSA in PBS, and then horseradish peroxidase-labelled ExtravidinTM (Sigma, St. Louis, 
MO, USA) diluted 1:400 in 1% (w/v) BSA in PBS. Colour was developed using 3.3 
diaminobenzidine-nickel and the nuclei were counterstained with Mayer’s haematoxylin. 
 
Statements 
Animal procedures were conducted in accordance with the United Kingdom Animals 
(Scientific Procedures) Act 1986 (Home Office license PPL60/3773) and with the "Guide 
for the Care and Use of Laboratory Animals" published by the US National Institutes of 
Health (NIH publication No. 85-23, revised 1996).  
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 Supplement Figure Legends 
 
Supplement Figure I. Global miRNA profiling. (A) Design of the miRNA microarray 
study investigating PAH in hypoxic or monocrotaline-exposed rats. Each circle 
represents animal groups (minimum n = 5/group), with each hypoxia treatment being 
in red and each drug treatment in blue. The control group is represented in green. 
Each arrow represents a two-channel microarray experiment. (B) Heat map showing 
the expression level of all miRNA in the global profiling protocol. Refer to Supplement 
Table 1 for complete microarray dataset.  
 
Supplement Figure II.  q-PCR curves showing DICER and DROSHA expression 
level in the lung of hypoxic or monocrotaline-injected six weeks male rats. (A) 
In vivo q-PCR result showing the dysregulation of both DICER and DROSHA after a 
hypoxic/monocrotaline treatment. For every gene, the time point with the maximum 
dysregulation for both the models has been chosen and the results are showed in 
duplicate. (B) In vitro q-PCR result showing DICER downregulation in 24 hours 
hypoxic rat PAFs versus untreated cells. The q-PCR curves are shown in duplicate. 
 
Supplement Figure III.  q-PCR curves showing miRNA expression levels in the 
lung of hypoxic or monocrotaline-injected six weeks male rats. For every 
miRNA, the time point with the maximum dysregulation for both the models has been 
chosen and the results are showed in triplicate. One example of amplification curve 
has been chosen for miR-145, taken as negative control. 
 
Supplement Figure IV. Validation of miR-17/92 cluster in hypoxic and 
monocrotaline rats. q-PCR analysis of hypoxic and monocrotaline-injected rats after 
2, 7 and 21 days of exposition. Total RNA was extracted in quadruplicate from 
hypoxic (grey bars) or monocrotaline-injected (black bars) six weeks male rats. Time 
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 points and samples were tested in triplicate. Results were normalized to U87 values 
and expressed as relative fold change, with an arbitrary value of 1 assigned to the 
control group. (*p<0.05, **p<0.005, ***p<0.001 vs control samples).  
 
Supplement Figure V. miRNA expression is regulated by hypoxia in vitro in 
human cells. (A and B) q-PCR analysis of hypoxic fetal human PAFs (A) and human 
PAECs (B) showing the expression level of miR-21, miR-22, miR-30c and let-7f after 
24 hours of stimulation. These experiments were performed with total RNA extracted 
from both the control and the hypoxic cells. Results were normalized to Rnu-48 
values and expressed as relative fold change, with an arbitrary value of 1 assigned to 
the control group (*p<0.05, ***p<0.001 vs control samples). 
 
Supplement Figure VI: Assessment of miRNA target mRNA levels in rat lung 
following hypoxic and monocrotaline injuries. Total RNA was extracted from lung 
samples of hypoxic (grey bars) and monocrotaline-treated (black bars) rats. cDNA 
was prepared and mRNA levels were assessed by TaqMan analysis and plotted as 
fold change vs control samples. Results were normalized to GAPDH values. The 
miRNAs that possess predicted seed sequences for each target are indicated. 
(*p<0.05, **p<0.005, ***p<0.001 vs control samples). 
 
 
Supplement Table I. Absolute levels of miRNAs modulated during the 
progression of PAH. Values are means and standard deviations for miRNA of the 
intensities for each condition (at least n=5/group). 
 
Supplement Table II. Absolute levels of selected miRNAs. Raw values for 
miRNAs up- and down-regulated in PAH rats are shown. 
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 Supplement Table III. Absolute levels of miR-17/92 cluster. Raw values for miR-
17/92 cluster in PAH rats are shown. 
 
Supplement Table IV. Predicted targets for the three downregulated miRNAs 
miR-21, miR-22 and miR-30c. A list of potential targets for miR-21, miR-22 and miR-
30c, obtained through bioinformatic tools, is shown.  
 
Supplement Table V. Predicted targets for the two up-regulated miRNAs miR-
451 and miR-322. A list of potential targets in common between the two miRNAs, 
obtained through bioinformatic tools is shown. Proteins marked in red have been 
show to be targets also of the down-regulated miRNA group. 
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                              Group 1 Group 2 Group 3 
                              control Hypoxiaday 2 Hypoxia day 7 
Reporter Name Mean StDev Mean StDev Mean StDev 
rno-miR-322 1,066 326 1,109 345 931 484 
rno-miR-451 467 188 1,528 405 996 388 
rno-miR-21 1,686 739 1,862 594 1,840 1,126 
rno-let-7f 8,290 870 7,094 2,842 8,257 2,295 
rno-let-7a 9,747 1,309 8,573 3,011 10,983 3,372 
rno-miR-26b 2,709 1,131 2,034 906 1,349 882 
rno-miR-30b-5p 3,716 1,037 3,964 1,161 2,526 898 
rno-let-7d 6,525 638 5,423 2,355 7,001 2,474 
rno-miR-30c 4,085 849 4,285 982 3,181 980 
rno-miR-125a-5p 2,232 849 1,515 244 1,903 1,006 
rno-miR-30d 1,810 489 2,087 660 1,411 490 
rno-let-7c 8,762 1,669 7,642 2,817 10,755 3,730 
rno-miR-92b 309 107 204 50 370 210 
rno-miR-30e 535 288 758 413 277 145 
rno-miR-30a 2,082 669 2,517 1,022 1,415 662 
rno-miR-99a 294 70 439 99 344 89 
rno-miR-22 333 225 720 302 638 445 
rno-miR-126 11,056 2,611 12,492 1,942 10,000 3,716 
rno-miR-29c 594 362 521 345 219 164 
rno-miR-92a 567 188 445 85 715 337 
rno-miR-214 306 178 285 103 927 976 
rno-miR-191 1,535 257 1,526 423 1,500 543 
rno-let-7b 7,268 1,534 6,182 2,558 9,176 3,568 
rno-miR-146b 344 128 322 30 380 90 
rno-miR-24 2,724 875 3,264 867 3,218 1,904 
rno-miR-361 383 100 233 68 362 179 
rno-miR-140* 215 132 167 64 259 90 
rno-miR-222 223 129 243 84 306 91 
rno-miR-29a 2,271 704 2,324 879 1,542 638 
Supplement Table I. Absolute levels of miRNAs modulated during the progression of PAH 
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rno-miR-221 222 61 322 56 291 120 
rno-miR-143 1,870 775 2,597 817 2,229 1,238 
rno-miR-130a 250 110 422 139 375 165 
rno-miR-497 295 270 296 164 684 606 
rno-miR-322* 106 16 115 16 99 23 
rno-miR-210 21 8 32 9 54 19 
rno-miR-449a 47 26 69 10 156 116 
rno-miR-132 26 5 28 5 57 31 
rno-miR-19b 75 23 223 153 110 56 
rno-miR-151* 108 20 74 26 110 23 
rno-miR-301a 18 5 42 22 20 14 
rno-miR-100 200 53 259 89 170 53 
rno-miR-652 106 46 79 24 152 128 
rno-miR-101a 65 25 123 112 48 19 
 
rno-miR-336 9 6 8 4 14 5 
rno-miR-101b 43 12 84 28 47 22 
rno-miR-347 13 2 9 4 13 4 
rno-miR-184 17 9 15 4 26 22 
rno-miR-129 11 3 17 7 13 4 
rno-miR-429 245 76 217 39 181 82 
rno-miR-151 905 188 606 194 866 177 
rno-miR-195 3,062 423 3,110 183 2,940 469 
rno-miR-664 64 41 19 5 35 31 
rno-miR-26a 11,526 2,405 11,447 1,603 9,172 2,742 
rno-let-7e 2,978 1,147 2,338 1,645 3,034 1,400 
rno-miR-872* 25 9 31 8 19 5 
rno-miR-34a 296 261 245 112 496 431 
rno-miR-200b 1,161 283 781 267 972 318 
rno-miR-138 11 4 14 4 12 3 
rno-miR-205 39 14 42 10 40 9 
rno-miR-328 48 13 32 12 39 10 
rno-miR-352 664 406 465 361 379 382 
rno-miR-181a 650 287 866 194 654 397 
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rno-miR-144 10 3 23 16 12 5 
rno-miR-193 17 6 20 7 26 7 
rno-miR-34b 23 7 37 8 32 17 
rno-miR-28 147 60 96 13 98 36 
rno-miR-10a-5p 525 272 264 112 293 275 
rno-miR-375 692 144 431 144 535 165 
rno-miR-199a-5p 74 39 149 23 131 69 
rno-miR-29b 75 46 122 99 36 15 
rno-miR-133a 43 25 39 11 46 16 
rno-miR-450a 539 431 235 219 211 372 
rno-miR-139-5p 62 39 36 8 50 22 
rno-miR-15b 726 252 710 220 1,045 482 
rno-miR-29b-2* 19 4 17 6 16 4 
rno-miR-98 772 866 501 634 225 194 
rno-miR-203 103 67 49 16 61 23 
rno-miR-877 19 5 13 6 23 9 
rno-miR-126* 266 497 283 478 34 17 
rno-miR-103 481 271 465 164 562 193 
rno-miR-200c 1,295 301 906 273 1,604 784 
rno-miR-365 125 105 37 21 45 53 
rno-miR-185 195 75 137 47 181 51 
rno-miR-345-5p 44 29 30 12 51 28 
rno-miR-34c 63 47 68 24 76 35 
rno-miR-324-5p 35 11 28 12 34 7 
rno-miR-374 77 70 34 25 28 25 
rno-miR-1* 10 3 11 5 13 3 
rno-miR-17 199 29 240 75 256 85 
rno-miR-340-5p 24 19 11 4 13 2 
 
rno-miR-199a-3p 709 182 999 178 782 259 
rno-miR-217 15 2 12 3 16 3 
rno-miR-200a 211 80 340 83 197 132 
rno-miR-107 427 226 427 151 507 171 
rno-miR-30a* 145 66 108 31 125 57 
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rno-miR-125a-3p 24 6 21 5 28 9 
rno-miR-542-5p 26 10 19 6 22 7 
rno-miR-218 253 221 99 71 77 86 
rno-miR-150 1,551 399 1,490 154 1,687 326 
rno-miR-25* 20 4 17 5 19 5 
rno-miR-7a 53 48 18 9 29 34 
rno-miR-299 11 4 11 4 13 6 
rno-miR-23a 6,618 738 7,458 2,151 6,186 2,028 
rno-miR-499 18 13 11 4 10 6 
rno-miR-204 20 10 10 3 14 6 
rno-miR-127 18 6 26 5 19 8 
rno-miR-335 38 35 20 9 21 14 
rno-miR-378 73 46 67 22 70 22 
rno-miR-99b 577 210 580 185 705 246 
rno-miR-324-3p 27 5 23 9 25 7 
rno-miR-187 28 8 21 7 34 8 
rno-miR-106b 179 59 183 57 211 51 
rno-miR-341 11 3 22 17 16 5 
rno-miR-20a 245 27 256 48 266 33 
rno-miR-99b* 11 3 10 4 7 2 
rno-miR-223 173 150 104 87 96 110 
rno-miR-409-3p 15 6 16 7 21 11 
rno-miR-181b 111 95 61 45 52 47 
rno-miR-128 120 20 97 27 126 17 
rno-miR-142-5p 21 11 41 38 13 7 
rno-miR-30e* 98 79 49 38 45 49 
rno-miR-30c-2* 37 5 37 9 39 12 
rno-miR-145 4,950 1,562 5,756 2,691 7,329 4,154 
rno-miR-20b-5p 71 49 56 45 37 30 
rno-miR-141 73 33 114 29 68 40 
rno-miR-224 81 26 61 15 74 7 
rno-miR-122 22 10 22 14 29 13 
rno-let-7i 4,293 240 4,112 375 3,991 375 
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rno-miR-342-5p 33 9 20 8 32 11 
rno-miR-133b 37 18 39 7 41 13 
rno-miR-31 80 37 65 16 66 25 
rno-miR-186 23 10 34 22 19 8 
rno-miR-672 153 69 108 57 160 117 
rno-miR-503 21 5 28 11 25 7 
rno-miR-34c* 134 71 127 55 139 57 
rno-miR-181c 19 12 30 16 18 5 
rno-miR-18a 23 5 25 9 27 4 
rno-miR-542-3p 43 39 24 12 14 11 
 
rno-miR-16 4,051 727 4,686 672 4,517 578 
rno-miR-543 15 8 16 11 10 3 
rno-miR-23b 6,669 830 7,210 2,081 6,128 2,003 
rno-miR-146a 552 223 491 70 515 210 
rno-miR-152 236 81 253 63 241 84 
rno-miR-28* 50 13 44 8 52 4 
rno-miR-181d 70 62 53 35 31 14 
rno-miR-343 12 6 11 3 14 4 
rno-miR-7a* 17 10 29 26 14 6 
rno-miR-872 74 21 86 22 60 6 
rno-miR-296* 16 5 18 7 20 10 
rno-miR-1 20 13 120 218 14 5 
rno-miR-9 10 3 10 6 12 8 
rno-miR-142-3p 17 13 25 20 13 6 
rno-miR-351 34 23 22 6 21 6 
rno-miR-331 37 16 28 13 28 6 
rno-miR-29c* 23 4 28 5 26 7 
rno-miR-22* 36 11 43 14 35 11 
rno-miR-505 33 16 33 14 23 7 
rno-miR-23a* 20 3 19 10 24 5 
rno-miR-350 25 13 25 10 18 5 
rno-miR-10b 42 52 28 26 23 9 
rno-miR-24-2* 100 36 105 27 85 28 
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rno-let-7e* 13 2 20 18 13 2 
rno-miR-425 102 47 95 36 107 37 
rno-miR-194 40 6 40 7 31 5 
rno-miR-192 35 10 36 13 28 7 
rno-miR-674-5p 97 30 66 26 88 33 
rno-miR-30d* 11 1 14 8 11 3 
rno-let-7b* 20 5 30 22 19 5 
rno-miR-148b-3p 53 40 38 13 34 9 
rno-miR-130b 20 7 24 11 22 4 
rno-miR-182 78 33 90 61 79 19 
rno-miR-483 12 5 11 3 13 8 
rno-miR-333 21 8 19 5 22 9 
rno-miR-134 14 2 14 3 16 6 
rno-miR-183 88 14 98 40 107 12 
rno-miR-466b 11 3 11 8 9 4 
rno-miR-207 11 6 30 42 14 4 
rno-miR-320 643 303 507 151 728 252 
rno-miR-532-3p 21 14 27 18 15 7 
rno-miR-181a* 18 7 20 9 19 4 
rno-miR-674-3p 46 10 38 13 39 7 
rno-miR-598-5p 9 3 10 6 9 3 
rno-miR-484 21 8 18 9 20 8 
rno-miR-17-3p 14 4 13 4 13 3 
rno-miR-342-3p 134 96 74 27 101 59 
rno-miR-27a* 10 2 12 8 11 3 
 
rno-miR-125b-5p 3,117 675 3,445 343 3,312 868 
rno-let-7d* 32 20 37 24 22 2 
rno-miR-30c-1* 15 4 17 10 16 3 
rno-miR-27b 1,325 564 1,394 526 1,071 372 
rno-miR-883 9 5 8 4 8 2 
rno-miR-27a 1,534 653 1,443 548 1,135 525 
rno-miR-25 555 127 481 71 570 156 
rno-miR-376c 8 5 8 3 10 2 
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rno-miR-339-3p 21 9 17 9 15 3 
rno-miR-19a 12 2 21 14 14 3 
rno-miR-673 9 4 9 4 10 3 
rno-miR-93 118 63 118 33 136 66 
rno-miR-369-3p 9 5 9 4 8 2 
rno-miR-30b-3p 25 6 22 8 21 3 
rno-miR-377 86 109 428 619 201 337 
rno-miR-206 15 4 15 7 14 2 
rno-miR-532-5p 19 4 19 9 20 5 
 
 
 
 
Group 4 Group 5 Group 6 Group 7 
Hypoxia day 21 MCT day 2 MCT day 7 MCT day 21 
Mean StDev Mean StDev Mean StDev Mean StDev 
834 541 832 309 210 83 241 285 
1,539 928 1,008 462 1,335 449 479 187 
2,243 1,515 1,276 595 367 141 2,881 1,809 
6,035 3,257 7,401 2,801 2,560 485 6,359 1,982 
8,370 3,371 8,926 2,822 4,038 585 8,414 1,567 
1,294 962 2,300 1,199 451 89 1,142 1,251 
2,198 760 4,154 527 3,001 733 2,624 740 
5,241 3,148 5,922 2,275 2,262 584 4,962 2,137 
2,673 763 4,120 468 3,300 495 2,918 492 
1,147 507 1,652 744 758 142 1,221 514 
1,618 399 1,860 346 2,613 411 1,458 215 
9,467 4,038 8,240 1,813 4,809 554 8,983 1,339 
159 37 236 61 203 23 223 73 
402 132 580 91 429 154 340 166 
2,026 665 2,296 452 2,889 350 1,494 485 
290 89 404 117 444 81 280 83 
680 337 570 355 1,107 137 666 189 
12,414 4,410 11,342 3,751 15,687 3,943 7,308 2,378 
 at University of Glasgow Library on August 10, 2010 atvb.ahajournals.orgDownloaded from 
293 165 438 216 130 34 268 282 
381 89 484 111 401 52 434 111 
509 313 271 115 426 113 687 304 
1,486 341 1,458 438 2,386 667 2,427 874 
8,378 4,715 6,913 1,770 3,788 1,051 7,290 1,285 
515 339 284 37 275 102 604 174 
3,580 1,408 3,261 1,271 6,051 1,494 3,763 1,233 
243 23 328 71 321 62 371 73 
433 256 201 105 408 150 312 117 
270 132 255 83 425 113 477 183 
2,322 592 2,364 469 3,087 541 1,949 485 
318 64 344 109 372 118 424 69 
3,412 1,452 2,218 811 4,281 998 2,159 708 
443 210 479 247 687 259 429 109 
695 478 340 209 812 204 496 200 
119 5 111 14 90 11 62 7 
124 89 20 4 33 4 28 8 
48 12 69 30 43 17 105 38 
33 4 22 4 24 2 35 14 
140 40 155 33 147 66 88 39 
84 12 91 23 92 32 60 24 
27 7 36 12 20 6 35 12 
167 41 176 40 145 24 150 34 
72 12 118 21 78 29 57 13 
62 26 79 25 30 11 50 36 
 
18 12 13 4 19 9 15 4 
59 25 75 15 46 18 45 24 
12 3 12 2 28 29 10 4 
39 26 16 6 13 4 21 9 
17 9 13 5 21 10 8 5 
144 82 260 36 149 55 144 75 
767 101 693 104 876 282 674 138 
3,494 746 3,272 540 2,864 305 2,420 786 
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15 9 40 40 34 24 23 14 
10,994 5,024 10,736 3,871 17,943 2,717 11,200 4,091 
2,145 1,680 2,592 1,541 848 346 2,371 1,841 
21 6 30 3 17 7 22 13 
423 224 294 187 508 156 659 243 
738 312 1,048 326 705 109 772 199 
14 4 13 3 10 4 27 22 
29 6 46 6 26 8 33 15 
30 8 29 4 43 9 46 16 
215 188 477 442 99 77 237 240 
898 396 759 287 1,415 355 702 227 
13 3 13 3 10 3 12 3 
32 13 18 4 28 14 29 13 
43 25 52 27 38 9 43 19 
80 10 106 58 79 12 86 15 
252 115 306 194 127 38 222 147 
538 452 586 149 402 114 344 117 
212 182 117 76 153 38 128 36 
81 28 79 38 43 12 70 43 
80 76 46 32 189 237 39 13 
162 162 287 366 39 25 90 130 
42 23 64 28 23 8 29 16 
627 446 715 160 444 144 914 253 
17 5 22 3 14 7 23 7 
272 365 663 842 38 28 547 1,099 
54 29 78 49 35 7 55 36 
15 5 18 5 11 6 16 7 
38 15 277 435 32 15 58 74 
609 238 487 136 787 176 730 246 
1,096 300 1,181 219 1,180 242 1,195 155 
23 10 61 78 22 7 33 14 
240 83 150 13 187 63 214 68 
72 58 41 14 90 47 55 25 
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136 142 97 72 144 75 123 48 
46 31 33 7 52 17 49 22 
18 9 44 55 17 5 28 17 
11 5 13 5 20 14 9 3 
180 40 193 44 249 43 234 42 
12 5 12 4 12 4 12 3 
 
1,012 160 851 206 992 313 854 143 
30 33 17 4 19 6 22 9 
223 96 397 232 296 144 186 50 
564 220 457 124 677 118 665 216 
100 36 140 47 87 17 86 24 
20 3 22 6 20 10 16 5 
18 9 17 6 16 6 13 6 
92 49 106 100 37 13 76 46 
1,405 336 1,383 321 1,197 229 1,257 348 
18 6 17 7 218 438 17 6 
15 8 31 41 9 3 28 27 
24 22 15 5 19 13 21 8 
6,426 2,851 7,137 1,357 8,079 364 9,313 2,855 
9 4 12 6 8 2 14 6 
11 2 10 6 12 5 12 5 
19 4 19 8 20 10 14 5 
15 3 18 8 13 5 13 3 
96 44 75 21 195 221 80 27 
546 186 534 98 885 266 700 251 
29 14 25 5 36 5 29 9 
33 17 29 11 23 5 33 14 
221 51 175 38 253 35 218 61 
19 13 18 5 26 13 15 5 
211 68 239 21 257 20 271 52 
8 5 11 3 6 3 10 13 
56 27 107 64 49 21 84 41 
12 4 20 8 26 14 14 5 
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35 12 56 45 26 8 41 12 
115 31 102 21 90 23 100 43 
18 5 20 3 22 20 22 9 
31 5 66 71 29 9 42 16 
39 8 41 7 31 10 30 11 
8,116 4,638 6,097 3,380 9,359 1,975 7,536 2,748 
25 5 45 32 28 8 33 8 
77 27 95 32 89 32 72 14 
88 20 66 16 78 30 65 20 
243 481 22 13 26 7 24 13 
4,674 1,006 4,241 318 4,759 991 4,577 422 
25 5 27 12 25 9 26 13 
69 56 43 27 128 151 38 17 
122 70 79 37 97 51 69 24 
24 12 25 4 18 6 28 12 
157 159 143 47 64 20 130 72 
19 7 18 3 22 6 19 7 
157 25 148 24 133 65 213 75 
19 8 21 4 18 5 19 4 
27 9 20 8 26 8 31 9 
29 30 19 17 12 4 20 18 
 
4,333 1,100 4,895 1,071 5,076 611 4,758 676 
8 5 16 8 8 4 7 5 
6,101 2,783 6,887 1,087 6,951 1,004 8,485 2,170 
774 464 606 229 395 177 496 81 
279 139 269 39 193 81 177 60 
46 21 51 9 40 15 41 9 
30 13 52 42 25 14 33 10 
13 5 14 3 19 11 12 4 
22 18 13 4 12 5 19 7 
72 27 85 16 62 17 71 30 
27 18 21 9 31 23 29 13 
41 40 27 27 48 39 57 78 
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9 6 33 51 7 2 8 5 
14 4 16 6 10 5 15 4 
20 11 23 5 22 4 21 7 
30 12 27 4 38 13 29 3 
29 9 29 5 31 8 30 8 
32 9 45 12 33 7 37 10 
26 8 34 8 29 9 31 11 
23 5 18 3 22 2 23 11 
19 6 20 3 18 2 20 2 
21 7 27 27 13 4 16 6 
98 27 104 15 93 28 78 6 
13 4 13 3 11 4 11 2 
107 37 81 19 134 44 126 57 
42 20 41 3 35 8 35 14 
44 25 31 6 27 13 36 16 
90 46 85 12 93 37 114 66 
42 65 11 2 16 3 249 533 
16 3 23 8 20 10 18 9 
27 11 41 17 28 14 38 21 
17 4 17 4 22 7 19 4 
92 33 66 7 62 23 92 39 
18 6 14 10 19 13 16 7 
19 3 28 13 18 7 24 10 
13 4 15 3 17 12 10 4 
126 103 96 33 79 30 113 18 
13 12 10 3 7 4 14 9 
16 11 15 6 17 7 16 5 
665 321 626 112 740 212 691 224 
16 3 19 5 17 5 18 11 
15 5 22 4 20 4 19 9 
36 9 37 8 44 12 52 29 
7 6 9 2 16 15 6 4 
18 6 17 10 24 4 19 5 
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14 5 16 2 21 20 12 5 
87 103 98 49 57 18 200 309 
10 3 10 2 16 10 11 5 
 
2,825 389 3,383 499 3,355 609 3,191 1,291 
53 70 23 5 25 12 141 266 
15 6 13 1 13 6 14 7 
1,298 290 1,134 126 1,093 224 1,119 220 
10 3 8 4 9 8 35 61 
1,278 569 1,153 78 1,297 255 1,138 443 
570 219 512 88 595 129 594 117 
10 13 9 4 7 3 6 2 
14 9 15 5 24 26 13 7 
15 7 14 3 15 8 15 5 
11 4 9 4 21 32 38 65 
136 88 100 27 154 61 137 96 
11 7 8 3 7 3 27 44 
23 6 23 3 24 5 22 8 
236 457 73 96 703 1,429 90 124 
26 28 12 2 18 13 20 14 
19 6 17 3 23 14 20 8 
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miRNA CTR H day 2 H day 7 H day 21 M day 2 M day 7 M day 21 
rno-let-7a 7,729 9,439 14,993 9,542 11,972 3,058 10,101 
  10,540 11,385 13,685 8,116 5,174 4,613 6,258 
  8,832 11,260 10,171 12,824 6,837 4,200 7,714 
  9,897 5,651 6,613 7,891 10,664 4,272 8,240 
  10,024 5,129 9,454 3,476 9,985 4,045 9,757 
  11,458             
rno-let-7f 6,718 7,552 10,733 6,326 10,128 1,738 8,560 
  8,821 9,485 9,582 6,160 3,212 2,697 3,729 
  8,120 10,117 8,605 11,080 6,055 2,544 5,583 
  9,046 4,176 4,690 4,297 9,375 2,872 8,108 
  8,112 4,141 7,675 2,312 8,233 2,947 5,813 
  8,923             
rno-miR-322 1,194 643 579 816 876 169 211 
  1,136 1,386 546 1,142 300 354 71 
  1,413 1,188 1,647 1,563 889 194 94 
  872 1,457 667 215 1,072 142 742 
  1,271 872 1,216 436 1,023 193 89 
  508             
rno-miR-21 2,201 1,037 2,010 3,491 1,315 439 3,279 
  2,423 2,470 919 2,304 368 508 1,153 
  1,508 2,399 3,712 3,972 1,204 354 2,525 
  899 1,795 1,104 606 1,475 137 5,773 
  2,326 1,607 1,455 844 2,015 399 1,676 
  757             
rno-miR-22 386 770 526 512 372 1,118 639 
  128 286 314 576 1,114 1,199 878 
  143 572 157 380 603 1,196 735 
  657 920 1,209 680 599 869 366 
  159 1,053 982 1,251 160 1,152 711 
  524             
rno-miR-30c 4,399 3,186 2,048 1,743 3,460 3,129 2,967 
  4,042 3,566 2,348 3,738 3,869 2,729 2,188 
  5,389 4,068 4,445 2,717 4,365 3,459 3,069 
  3,347 5,216 3,430 2,186 4,234 3,126 3,549 
  4,338 5,388 3,632 2,979 4,672 4,056 2,816 
  2,994             
rno-miR-451 278 1,588 884 711 768 1,311 275 
  444 1,352 737 1,413 1,789 801 591 
  636 1,128 1,346 1,207 834 995 407 
  397 2,192 559 1,229 1,035 1,811 746 
  299 1,378 1,455 3,133 613 1,757 379 
  749             
 
Supplement Table II. Absolute levels of selected miRNAs 
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miR-17/92 cluster  
      
        
 
CTR H day 2 H day 7 H day 21 M day 2 M day 7 M day 21 
rno-miR-17 180 234 161 130 217 249 225 
 184 164 338 201 260 246 272 
 197 169 227 155 160 194 278 
 214 323 352 184 158 314 175 
 169 308 202 232 172 242 218 
 250             
rno-miR-18a 29 21 28 16 8 28 23 
 23 13 23 28 20 37 41 
 16 26 30 25 25 21 30 
 19 35 32 40 30 30 21 
 22 31 25 24 18 16 40 
 28             
rno-miR-19a 12 11 15 7 9 27 12 
 12 33 17 12 11 16 17 
 10 8 9 23 16 16 12 
 9 39 14 21 17 10 14 
 13 13 14 11 15 8 23 
 16        
rno-miR-20a 268 272 241 216 239 284 264 
 236 175 235 219 272 233 353 
 214 257 263 300 238 267 281 
 276 271 277 210 220 247 212 
 216 302 316 108 225 252 248 
 259             
rno-miR-19b 94 109 156 118 138 203 44 
 83 144 90 199 194 80 113 
 80 132 73 161 170 218 67 
 39 479 51 102 166 79 141 
 56 251 181 121 109 158 76 
 100             
rno-miR-92a 418 487 519 500 490 438 509 
 573 371 1,294 401 391 390 268 
 922 524 708 380 454 415 392 
 531 337 599 372 413 316 451 
 553 507 453 249 670 444 553 
 405             
 
Supplement Table III. Absolute levels of miR-17/92 cluster 
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Target name Target of Target function 
KCNJ6 miR-22 and miR-30c potassium inwardly-rectifying channel, subfamily J, member 6  
PPP2R5E miR-21 and miR-22 protein phosphatase 2, regulatory subunit B(B56), epsilon isoform  
NFAT5 miR-22 and miR-30c nuclear factor of activated T-cells 5  
TACC1 miR-21 and miR-30c transforming, acidic coiled-coil containing protein 1  
ADARB1 miR-22  adenosine deaminase, RNA-specific, B1  
TGFBR1 miR-22  transforming growth factor, beta receptor 1   
TGFBRAP1  miR-22  transforming growth factor, beta receptor associated protein 1  
RBPSUH miR-21 recombining binding protein suppressor of hairless (Drosophila) 
TNRC6A miR-30c trinucleotide repeat containing 6a  
YWHAZ miR-30c 
tyrosine 3-monooxygenase/tryptophan  5-monooxygenase activation protein, 
zeta polypeptide 
 
Supplement Table IV: Predicted targets for the three downregulated miRNAs miR-21, miR-22 and  
miR-30c 
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Target name Also target of Target function 
 ANKFY1    ankyrin repeat and FYVE domain containing 1 
 ANKS1A    ankyrin repeat and sterile alpha motif domain containing 1A 
 BCL9    B-cell CLL/lymphoma 9 
 CYBRD1    cytochrome b reductase 1 
 DHX37    DEAH (Asp-Glu-Ala-His) box polypeptide 37 
 DISP2    dispatched homolog 2 (Drosophila) 
 ELK4    ELK4, ETS-domain protein (SRF accessory protein 1) 
 FBXO21    F-box protein 21 
 GLS    glutaminase 
 GRM2    glutamate receptor, metabotropic 2 
 KCNJ6 Mir-22 and miR-30c  potassium inwardly-rectifying channel, subfamily J, member 6 
 KCNK5    potassium channel, subfamily K, member 5 
 KIAA0174    KIAA0174 
 MGAT4B   
 mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B 
 MOBKL1B    MOB1, Mps One Binder kinase activator-like 1B (yeast) 
 NFAT5 Mir-22 and miR-30c  nuclear factor of activated T-cells 5, tonicity-responsive 
 PATL1    protein associated with topoisomerase II homolog 1 (yeast) 
 PDZD8    PDZ domain containing 8 
 PLXNC1    plexin C1 
 PMEPA1    prostate transmembrane protein, androgen induced 1 
 PPM1L    protein phosphatase 1 (formerly 2C)-like 
 RAB22A Mir-22 and miR-30c  RAB22A, member RAS oncogene family 
 RCAN2    regulator of calcineurin 2 
 RGD1561661    similar to Ferritin light chain (Ferritin L subunit) 
 SAR1A    SAR1 homolog A (S. cerevisiae) 
 SLC11A2    solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 
 SLC12A2    solute carrier family 12 (sodium/potassium/chloride transporters), member 2 
 SLC25A22    solute carrier family 25 (mitochondrial carrier: glutamate), member 22 
 SNX11    sorting nexin 11 
 SNX27    sorting nexin family member 27 
 TACC1 Mir-21 and miR-30c  transforming, acidic coiled-coil containing protein 1 
 TGFA    transforming growth factor, alpha 
 TPCN1    two pore segment channel 1 
 UBE2K Mir-21 and miR-22  ubiquitin-conjugating enzyme E2K (UBC1 homolog, yeast) 
 UBE4A    ubiquitination factor E4A (UFD2 homolog, yeast) 
 UNC5C    unc-5 homolog C (C. elegans) 
 ZBTB39    zinc finger and BTB domain containing 39 
 ZNF592    zinc finger protein 592 
 
Supplement Table V. Predicted targets for the two up-regulated miRNAs miR-451 and miR-322 
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